These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A comparative study on the interactions of human copper chaperone Cox17 with anticancer organoruthenium(II) complexes and cisplatin by mass spectrometry. Li L; Guo W; Wu K; Wu X; Zhao L; Zhao Y; Luo Q; Wang Y; Liu Y; Zhang Q; Wang F J Inorg Biochem; 2016 Aug; 161():99-106. PubMed ID: 27235272 [TBL] [Abstract][Full Text] [Related]
6. Spectral, structural, and electrochemical properties of ruthenium porphyrin diaryl and aryl(alkoxycarbonyl) carbene complexes: influence of carbene substituents, porphyrin substituents, and trans-axial ligands. Li Y; Huang JS; Xu GB; Zhu N; Zhou ZY; Che CM; Wong KY Chemistry; 2004 Jul; 10(14):3486-502. PubMed ID: 15252795 [TBL] [Abstract][Full Text] [Related]
7. A Bioactive l-Phenylalanine-Derived Arene in Multitargeted Organoruthenium Compounds: Impact on the Antiproliferative Activity and Mode of Action. Movassaghi S; Leung E; Hanif M; Lee BYT; Holtkamp HU; Tu JKY; Söhnel T; Jamieson SMF; Hartinger CG Inorg Chem; 2018 Jul; 57(14):8521-8529. PubMed ID: 29949354 [TBL] [Abstract][Full Text] [Related]
9. Electrophilic Activation of Oxidized Sulfur Ligands and Implications for the Biological Activity of Ruthenium(II) Arene Anticancer Complexes. Sriskandakumar T; Behyan S; Habtemariam A; Sadler PJ; Kennepohl P Inorg Chem; 2015 Dec; 54(23):11574-80. PubMed ID: 26599813 [TBL] [Abstract][Full Text] [Related]
10. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of interstrand migration of organoruthenium anticancer complexes within a DNA duplex. Wu K; Luo Q; Hu W; Li X; Wang F; Xiong S; Sadler PJ Metallomics; 2012 Feb; 4(2):139-48. PubMed ID: 22262368 [TBL] [Abstract][Full Text] [Related]
15. Design of Ru-arene Complexes for Antitumor Drugs. Su W; Li Y; Li P Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728 [TBL] [Abstract][Full Text] [Related]
16. Anticancer activity of Ru- and Os(arene) compounds of a maleimide-functionalized bioactive pyridinecarbothioamide ligand. Hanif M; Moon S; Sullivan MP; Movassaghi S; Kubanik M; Goldstone DC; Söhnel T; Jamieson SM; Hartinger CG J Inorg Biochem; 2016 Dec; 165():100-107. PubMed ID: 27470012 [TBL] [Abstract][Full Text] [Related]
17. Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol. Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP Dalton Trans; 2019 Apr; 48(16):5352-5360. PubMed ID: 30942794 [TBL] [Abstract][Full Text] [Related]
19. New ruthenium(II) arene complexes of anthracenyl-appended diazacycloalkanes: effect of ligand intercalation and hydrophobicity on DNA and protein binding and cleavage and cytotoxicity. Ganeshpandian M; Loganathan R; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M Dalton Trans; 2014 Jan; 43(3):1203-19. PubMed ID: 24177707 [TBL] [Abstract][Full Text] [Related]
20. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]